These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 11862382

  • 1. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M, Fondaneche MC, Vedrenne J, Barbieri G, Wiszniewski W, Picard C, Cant AJ, Steimle V, Charron D, Alca-Loridan C, Fischer A, Lisowska-Grospierre B.
    Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
    [Abstract] [Full Text] [Related]

  • 2. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V, Otten LA, Zufferey M, Mach B.
    Cell; 1993 Oct 08; 75(1):135-46. PubMed ID: 8402893
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 08; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M, Masternak K, Zufferey M, Barras E, Reith W.
    Mol Cell Biol; 2005 Oct 15; 25(19):8607-18. PubMed ID: 16166641
    [Abstract] [Full Text] [Related]

  • 9. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
    Peijnenburg A, Gobin SJ, van Eggermond MC, Godthelp BC, van Graafeiland N, van den Elsen PJ.
    J Immunol; 1997 Sep 15; 159(6):2720-7. PubMed ID: 9300692
    [Abstract] [Full Text] [Related]

  • 10. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.
    Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411
    [Abstract] [Full Text] [Related]

  • 11. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 25; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 15. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA, Leibundgut-Landmann S, Huarte J, Kos-Braun IC, Lavanchy C, Barras E, Borisch B, Steimle V, Acha-Orbea H, Reith W.
    Eur J Immunol; 2006 Jun 25; 36(6):1548-58. PubMed ID: 16703565
    [Abstract] [Full Text] [Related]

  • 16. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W.
    Nat Genet; 1998 Nov 25; 20(3):273-7. PubMed ID: 9806546
    [Abstract] [Full Text] [Related]

  • 17. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M, Jager M, Ono SJ.
    Exp Mol Pathol; 2007 Feb 27; 82(1):68-76. PubMed ID: 16650406
    [Abstract] [Full Text] [Related]

  • 19. Mutation in the class II trans-activator leading to a mild immunodeficiency.
    Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B.
    J Immunol; 2001 Aug 01; 167(3):1787-94. PubMed ID: 11466404
    [Abstract] [Full Text] [Related]

  • 20. [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells].
    Guo R, Zou P, Fan HH, Cui L, Cao YL, Zheng B, Gao L, Gao F, Lu HZ.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 01; 24(12):636-9. PubMed ID: 14761611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.